Objective Psychosis is one of the most debilitating complications of Parkinson disease (PD).
Although research on PD psychosis has been focused on the study of well-structured visual …

Investigation into neuropsychiatric symptoms in Parkinson's disease (PD) is sparse and
current drug development is mainly focused on the motor aspect of PD. The tight association …

Levodopa (L‐dopa) remains the basis of pharmacological treatment of Parkinson's disease
(PD). However, L‐dopa therapy is associated with the development of complications and …

Background: PD psychosis is often associated with cognitive impairment, including
dementia, and involves dopaminergic, serotonergic, and cholinergic mechanisms. Objective …

Psychosis, manifested through formed visual hallucinations or minor hallucinations, is a
common non-motor symptom of Parkinson's disease (PD). The pathogenesis of psychosis in …

Objective The objective of the current study was to compare the microstructural integrity of
the white matter (WM) tracts in patients having Parkinson disease (PD) with and without …

Importance Cognitive and visual impairments in Parkinson's Disease Psychosis (PDP) raise
the question of whether a specific profile of impaired cognition and visual function is linked …

Inefficient integration between bottom-up visual input and higher order visual processing
regions is implicated in visual hallucinations in Parkinson's disease (PD). Here, we …

Background Dyskinesia is a troublesome complication of long-term dopaminergic
medications in Parkinson's disease (PD) patients. Many factors are reported to be …

To gain insight into possible underlying mechanism (s) of visual hallucinations (VH) in
Parkinson's disease (PD), we explored changes in local oscillatory activity in different …